COYA Therapeutics founder steps down, appoints Pavao to board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director
April 2, 2026 8:00 AM EDTHoward Berman, Ph.D., the Companys Founder and current Executive Chairman and Director, has stepped down from his roles, following the CEO transition process initiated in November 2024. Mark H. Pavao, a senior pharma and biotech executive, joins the Board as an independent director.
HOUSTON--(BUSINESS WIRE)-- Coya Therapeutics, Inc.... More
